Federal drug studies are filled with problems when it comes to data on opiod use.
In a pronouncement issued Wednesday, the Trump Administration’s Opioid Commission has ignored the voluminous research finding that states with medical marijuana availability have fewer opiate-related overdoses, hospitalizations, and traffic accidents, as well as less opiate use and abuse than do states without medical marijuana laws.
Instead, in a letter to Trump, commission chair and New Jersey Gov. Chris Christie harkens to a single study using decades-old data. “Recent research out of the NIH’s National Institute on Drug Abuse found that marijuana use led to a 2 ½ times greater chance that the marijuana user would become an opioid user and abuser,” the letter states. “The Commission found this very disturbing.”